DYN logo

Dyne Therapeutics, Inc. (DYN) Non Current Assets

Annual Non Current Assets:

$31.95M-$3.75M(-10.51%)
December 31, 2024

Summary

  • As of today, DYN annual long term assets is $31.95 million, with the most recent change of -$3.75 million (-10.51%) on December 31, 2024.
  • During the last 3 years, DYN annual non current assets has fallen by -$11.32 million (-26.15%).
  • DYN annual non current assets is now -26.15% below its all-time high of $43.27 million, reached on December 31, 2021.

Performance

DYN Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Quarterly Non Current Assets:

$60.80M+$29.75M(+95.85%)
September 30, 2025

Summary

  • As of today, DYN quarterly long term assets is $60.80 million, with the most recent change of +$29.75 million (+95.85%) on September 30, 2025.
  • Over the past year, DYN quarterly non current assets has increased by +$28.34 million (+87.33%).
  • DYN quarterly non current assets is now at all-time high.

Performance

DYN Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

DYN Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-10.5%+87.3%
3Y3 Years-26.1%+46.7%
5Y5 Years+1805.5%+3625.3%

DYN Non Current Assets Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-26.1%at lowat high+95.8%
5Y5-Year-26.1%+1805.5%at high+3625.3%
All-TimeAll-Time-26.1%>+9999.0%at high+3625.3%

DYN Non Current Assets History

DateAnnualQuarterly
Sep 2025
-
$60.80M(+95.9%)
Jun 2025
-
$31.04M(-1.7%)
Mar 2025
-
$31.57M(-1.2%)
Dec 2024
$659.28M(+409.6%)
$31.95M(-1.5%)
Sep 2024
-
$32.45M(-3.3%)
Jun 2024
-
$33.56M(-1.7%)
Mar 2024
-
$34.14M(-4.4%)
Dec 2023
$129.38M(-51.3%)
$35.71M(-3.6%)
Sep 2023
-
$37.03M(-3.2%)
Jun 2023
-
$38.25M(-3.0%)
Mar 2023
-
$39.43M(-3.2%)
Dec 2022
$265.59M
$40.73M(-1.7%)
DateAnnualQuarterly
Sep 2022
-
$41.45M(-1.5%)
Jun 2022
-
$42.09M(-2.8%)
Mar 2022
-
$43.31M(+0.1%)
Dec 2021
$382.39M(+9.5%)
$43.27M(+2.5%)
Sep 2021
-
$42.22M(+621.8%)
Jun 2021
-
$5.85M(+26.0%)
Mar 2021
-
$4.64M(+9.3%)
Dec 2020
$349.09M(+2265.2%)
$4.25M(+160.2%)
Sep 2020
-
$1.63M(-3.4%)
Jun 2020
-
$1.69M(+0.8%)
Dec 2019
$14.76M(+80.9%)
$1.68M
Dec 2018
$8.16M
-

FAQ

  • What is Dyne Therapeutics, Inc. annual long term assets?
  • What is the all-time high annual non current assets for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. annual non current assets year-on-year change?
  • What is Dyne Therapeutics, Inc. quarterly long term assets?
  • What is the all-time high quarterly non current assets for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. quarterly non current assets year-on-year change?

What is Dyne Therapeutics, Inc. annual long term assets?

The current annual non current assets of DYN is $31.95M

What is the all-time high annual non current assets for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high annual long term assets is $43.27M

What is Dyne Therapeutics, Inc. annual non current assets year-on-year change?

Over the past year, DYN annual long term assets has changed by -$3.75M (-10.51%)

What is Dyne Therapeutics, Inc. quarterly long term assets?

The current quarterly non current assets of DYN is $60.80M

What is the all-time high quarterly non current assets for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high quarterly long term assets is $60.80M

What is Dyne Therapeutics, Inc. quarterly non current assets year-on-year change?

Over the past year, DYN quarterly long term assets has changed by +$28.34M (+87.33%)
On this page